This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Pharmabcine Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Beom Yong Park: Innovator in Antibody Development
Introduction
Beom Yong Park is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work is recognized for its potential impact on medical treatments.
Latest Patents
Beom Yong Park holds a patent for an "ANTI-TIE2 ANTIBODY AND USE THEREOF." This innovation showcases his expertise in creating targeted therapies that could enhance treatment options for various diseases. He has 1 patent to his name, reflecting his commitment to advancing medical science.
Career Highlights
Currently, Beom Yong Park is associated with Pharmabcine Inc., a company dedicated to developing innovative therapies. His role at Pharmabcine allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Beom Yong Park has worked alongside talented colleagues, including Eun-Ah Lee and Nu Ri Kang. Their combined efforts in research and development have fostered a collaborative environment that promotes innovation.
Conclusion
Beom Yong Park is a distinguished inventor whose work in antibody development is paving the way for future medical advancements. His contributions to Pharmabcine Inc. and the biotechnology field are commendable and hold promise for improving patient care.